Regular check-ins help track progress and make sure the medication continues to support your overall health
Most patients notice marked improvements after several weeks of consistent use and careful dose adjustment
For most patients, the most effective longterm strategy after achieving a target weight is to continue GLP1 treatment
Understanding these distinctions, alongside your medical history and comorbidities, enables you and your healthcare provider to select the most suitable option for managing type 2 diabetes or weight
Glucagon-like peptide-1 (GLP-1) receptor agonists are now an established group of medications for the treatment of type 2 diabetes
But sometimes the correct move is to slow the titration, review meal size and meal composition, improve hydration, adjust activity expectations temporarily, or reassess whether the medication is still the right choice